NOVEL P2X7R ANTAGONISTS AND THEIR USE
The present application is directed to novel P2X7R antagonists that are N-indol-3-yl-acetamide and N-azaindol-3-yl-acetamide compounds, pharmaceutical compositions comprising the same and their use for the prophylactic or therapeutic treatment of diseases mediated by P2X7R activity.
Saved in:
Main Author | |
---|---|
Format | Patent |
Language | English Korean |
Published |
18.01.2012
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present application is directed to novel P2X7R antagonists that are N-indol-3-yl-acetamide and N-azaindol-3-yl-acetamide compounds, pharmaceutical compositions comprising the same and their use for the prophylactic or therapeutic treatment of diseases mediated by P2X7R activity. |
---|---|
Bibliography: | Application Number: KR20117026988 |